Skip to main content
Equibles
MIST logo

MIST · Milestone Pharmaceuticals Inc. · Webcasts, Transcripts & Audio

Track MIST — free

Use MIST with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MIST.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.81 -0.01 (-0.74%) At close · Oct 2
Rebalance outlook locked
Market Cap
$98.15M
Shares
124.50M
Volume · Oct 2 769.55K Avg daily vol (3M) 1.42M

Milestone Pharmaceuticals Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Milestone Pharmaceuticals Inc. (MIST), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $238,000 −$26.07M '26 Q1 26-05-13 LATEST · $559,000 −$28.61M '26 Q2 26-08-12
Earnings call
FY26 · Q2
2026-08-12
Milestone Pharmaceuticals Inc. (MIST) Q2 2026 Earnings Call Transcript
Confident tone Commercial launch of Cardamist in PSVT Prescriber adoption and script growth International regulatory expansion
Revenue
$559,000
Diluted EPS
$-0.21
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call Transcript
Confident tone Cardamist commercial launch Payer coverage and formulary access AFib RVR Phase 3 development
Revenue
$238,000
Diluted EPS
$-0.20
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-20
Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call Transcript
Confident tone Commercial launch execution Emergency department / hospital burden opportunity Financial position and runway
Results not yet reported
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-03-03
Milestone Pharmaceuticals Inc. (MIST) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY24 · Q2
2024-08-08
Milestone Pharmaceuticals Inc. (MIST) Q2 2024 Earnings Call
Diluted EPS
$-0.14
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q3
2023-11-13
Milestone Pharmaceuticals Inc. (MIST) Q3 2023 Earnings Call
Diluted EPS
$-0.35
Audio Transcript Slides 8-K10-Q
Showing 1–6 of 6 webcasts
Key facts CIK 1408443 CUSIP 59935V107 13F (30d) 1 filings 1 filers Visit website Investor relations